Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.41%
#3 Cysic Cysic +25.00%
#4 Velvet Velvet +21.00%
#5 Fabric Protocol Fabric Protocol +18.27%
#6 Bedrock Bedrock +17.29%
#7 Nillion Nillion +16.73%
#8 Nockchain Nockchain +14.69%
#9 Perle Perle +12.86%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Rang în acțiuni #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Preț acțiune
$0.00060315
Ultima sincronizare: 2024-09-27
Capitalizare de piață
$1.65M
Schimbare (1 zi)
19.64%
Schimbare (1 an)
0.00%
Țară
SE
Tranzacționează Amniotics AB (publ) (AMNI)

Categorie

Healthcare
Raport P/B pentru Amniotics AB (publ) (AMNI)
Raport P/B la data de August 2026 TTM: 0.98
Conform celor mai recente rapoarte financiare și prețului acțiunilor Amniotics AB (publ), raportul P/B actual (TTM) este 0.98. La sfârșitul anului 2022, compania avea un P/B de 43.73.
Istoricul raportului P/B pentru Amniotics AB (publ) din 2018 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) 0.98 -40.17%
2023 1.63 -96.28%
2022 43.73 263.99%
2021 12.01 -34.02%
2020 18.21 -69.40%
2019 59.51 -75.80%
2018 245.87 0.00%
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 550.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 540.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 254.92%
BE